RBC Capital analyst Leonid Timashev maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price target of ...

HSBC is preparing to wind down its M&A and equity capital markets businesses in Europe, the UK and the Americas as part of a ...

RBC Capital analyst Jonathan Atkin maintained a Hold rating on Verizon (VZ – Research Report) on January 24 and set a price target of $42.00.

RBC Capital Markets has promoted Adam Ragol-Levy to head of European and Asian product, multi-asset agency solutions. The appointment follows three years serving as global multi-asset product manager ...

Investing.com -- Analysts at RBC Capital Markets have initiated coverage on two Spanish banks, Bankinter (BME:BKT) and CaixaBank (BME:CABK), flagging their prospects in a challenging European ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp., according to people familiar with the matter. The partnership at ...

Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own ...

RBC Capital Markets analyst Pammi Bir published a look ahead to 2025 for REITs and emphasized four top picks, Scotiabank analyst Ovais Habib expects significant profit margin growth for precious ...

VW produces and sells vehicles worldwide. Its Germanness is an important selling point, but the company is equally at home in China, Brazil and the US. Its dependence on foreign markets may soon ...

On Tuesday, RBC Capital Markets adjusted its price target for Sherwin-Williams (NYSE:SHW) stock, listed on the New York Stock Exchange under the ticker NYSE:SHW, reducing it to $438 from the ...

Street Talk understands the Wall Street firm’s head of equity capital markets and head of syndicate left the firm just before Christmas and annual bonus season. Lamshed joined Goldman Sachs in ...

Capital markets day postponed due to CEO medical procedure Weaker production, refining margins and trading to hit profit Shares down nearly 3% after underperforming peers in past year Jan 14 ...